| 56 | 5 | 490 |
| 下载次数 | 被引频次 | 阅读次数 |
目的探讨维吾尔族和汉族女性乳腺癌患者临床病理学参数的差异性。方法在新疆医科大学第一附属医院病理科医院信息系统(HIS)中检索2008年1月-2014年1月储存的维吾尔族及汉族女性原发性乳腺癌患者的临床病理信息,按临床病理学参数归类,运用统计学方法进行回顾性对比分析。结果共收集符合条件的女性乳腺癌患者1 366例,其中维吾尔族294例,汉族1 072例,维、汉族女性乳腺癌患者人数之比约为1∶4。与汉族患者相比,维吾尔族患者的发病年龄年轻化,临床分期较晚,恶性程度较高,淋巴结转移数目偏多,表皮生长因子受体2(Her-2)阳性表达患者较多,差异均具有统计学意义(P<0.05)。维、汉族乳腺癌患者的临床病理类型均以浸润性非特殊癌为主,并且维吾尔族女性孕激素受体(PR)阴性表达者居多,差异均有统计学意义(P<0.05),雌激素受体(ER)的表达无明显差异(P>0.05)。结论对年龄<35岁维吾尔女性患者进行早期乳腺肿块定期普查或早期筛查并做到早诊早治,具有重要的肿瘤预防意义;维吾尔族女性乳腺癌患者治疗模式与汉族女性乳腺癌患者显著不同,临床靶向治疗应当区别对待。
Abstract：Objective To compare the clinicopathological information of female breast cancer patients between Uyghur and Han.Methods The clinicopathological information was retrieved and retrospectively analyzed from January 2008 to January 2014 between Uyghur and Han female patients with breast cancer in the department of pathology,the First Affiliated Hospital of Xinjiang Medical University.The data were analyzed by statistical methods using SPSS 17.0version software.Results There were 1 366 cases of breast cancer patients were retrieved and recruited,of whom there were 294 Uyghur female patients and1 072 Han female patients.The ratio of Uyghur to Han is about 1∶4.Compared with Han patients,there was a significant difference in age of disease,clinical stage,lymph node metastasis and human epidermal growth factor receptor 2(Her-2)positive expression(P<0.05)in Uyghur female patients.The chief histopathological subtypes of the two ethnic groups were nonspecific invasive carcinoma(P<0.05),and progesterone receptor(PR)expression was significantly different between Han and Uyghur patients(P <0.05),but there was no significant difference of estrogen receptor(ER)expression between Han and Uyghur patients.Conclusion There would be much prophylactic significance of early examination for breast cancer in Uyghur female patients with breast lesion whose ages were below 35years;given the different expression of Her-2and PR between Han and Uyghur female patients,clinical therapy should be made differently.
[1]Ban KA,Godellas CV.Epidemiology of breast cancer[J].Surg Oncol Clin N Am,2014,23(3):409-422.
[2]Ziegler RG,Anderson WF,Gail MH.Increasing breast cancer incidence in China:the numbers add up[J].J Natl Cancer Inst,2008,100(19):1339-1341.
[3]Fan L,Strasser-Weippl K,Li JJ,et al.Breast cancer in China[J].Lancet Oncol,2014,15(7):e279-289.
[4]Fan L,Zheng Y,Yu KD,et al.Breast cancer in a transitional society over 18years:trends and present status in Shanghai,China[J].Breast Cancer Res Treat,2009,117(2):409-416.
[5]Yu ZG,Jia CX,Geng CZ,et al.Risk factors related to female breast cancer in regions of Northeast China:a 1:3 matched case-control population-based study[J].Chin Med J(Engl),2012,125(5):733-740.
[6]Paxton RJ,Taylor WC,Chang S,et al.Lifestyle behaviors of African American breast cancer survivors:a Sisters Network,Inc.study[J].PloS One,2013,8(4):e61854.
[7]Azaiza F,Cohen M.Health beliefs and rates of breast cancer screening among Arab women[J].J Womens Health(Larchmt),2006,15(5):520-530.
[8]Ferguson J,Chamberlain P,Cramer HM,et al.ER,PR,and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas:a comparison study with formalin-fixed cell blocks and surgical biopsies[J].Diagn Cytopathol,2013,41(7):575-581.
[9]Zheng S,Bai JQ,Li J,et al.The pathologic characteristics of breast cancer in China and its shift during 1999-2008:a national-wide multicenter cross-sectional image over 10years[J].Int J Cancer,2012,131(11):2622-2631.
[10]Wang K,Ren Y,Huang R,et al.Application of intraoperative frozen section examination in the management of female breast cancer in China:a nationwide,multicenter 10-year epidemiological study[J].World J Surg Oncol,2014,12(1):225.
[11]Calvo FA,Sallabanda M,Sole CV,et al.Intraoperative radiation therapy opportunities for clinical practice normalization:Data recording and innovative development[J].Rep Pract Oncol Radiother,2014,19(4):246-252.
[12]Schellong G,Riepenhausen M,Ehlert K,et al.Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence-an observational study with up to 33-year follow-up[J].Dtsch Arztebl Int,2014,111(1-2):3-9.
[13]Shim SJ,Park W,Huh SJ,et al.The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0:a multicenter,retrospective study(KROG 12-05)[J].Int J Radiat Oncol Biol Phys,2014,88(1):65-72.
[14]Dean SJ,Perks CM,Holly JM,et al.Loss of PTEN expression is associated with IGFBP2expression,younger age,and late stage in triple-negative breast cancer[J].Am J Clin Pathol,2014,141(3):323-333.
[15]Wang CH,Li JZ,Zhang W.Breast cancer molecular subtypes of Uygur and Han in Xinjiang of China[J].Int J Clin Exp Med,2014,7(4):1116-1121.
[16]Enewold L,Zhou J,McGlynn KA,et al.Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries[J].Cancer,2012,118(5):1397-1403.
[17]Baquet CR,Commiskey P.Socioeconomic factors and breast carcinoma in multicultural women[J].Cancer,2000,88(5Suppl):1256-1264.
[18]Zhang L,Jiang M,Zhou Y,et al.Survey on breast cancer patients in China toward breast-conserving surgery[J].Psycho oncology,2012,21(5):488-495.
基本信息:
中图分类号:R737.9
引用信息:
[1]崔文丽,刘霞,郑树涛,等.新疆维吾尔族和汉族女性乳腺癌临床病理学参数比较及分析[J],2014,37(10):1272-1275.
基金信息:
新疆维吾尔自治区自然科学基金面上项目(2014211C032)